Leveraging Technology in Phase I Clinical Trials
In this ISR research report, discover three major findings that are driving technology adoption in early phase trials.
White Paper
eClinical Trends Among Small Biopharma Organizations and CROs
Explore survey results from 150 biopharma, biotech, and CRO decision-makers on eClinical technology trends in 2024.
Utilization of Patient-Reported Outcomes for Medical Device Trials
Medical device sponsors are diversifying study formats, using ePRO tools like apps and web-based solutions. A survey by Medrio and studioID shows that over 90% find ePRO valuable for device trials.
Patient Engagement Guide for Sponsors and CROs
Now, more than ever, sponsors and CROs need to prioritize including patient engagement in their study builds from the ground-up. This involves defining processes to remove barriers for access, increasing awareness and education for clinical trials, and creating effective exchanges between patients and their clinicians.
How Sponsors Can Achieve Operational Efficiency with RTSM
When your trials rely on an investigational product (IP), your study timeline, budget, and overall success are closely tied to having the right product available at the right time and site. Once randomization is added in, sponsors can struggle to maintain an increasingly complex supply chain. Achieve operational efficiency with RTSM.
The Rise of Hybrid Trials
Are your clinical trials equipped for a modern world? Prior to 2020, the answer was likely not very much.
Your Consent Can Make or Break Your Studies
Disruptions due to COVID-19 paired with a slew of new guidance from regulatory bodies has catapulted the clinical trial industry into a period of digital transformation.1 More sponsors and CROs are beginning to adopt decentralized solutions and embrace digital workflows, yet informed consent continues to rely heavily on paper-based processes. Lots and lots of paper.
Embracing the Future of Hybrid Trials
Hybrid clinical trial models aren’t new, but they have grown from a novelty to a necessity over the past decade.1 While the benefits of hybrid trials cannot be overstated, many decision makers still view it as a temporary measure. Others remain weary or unsure of how to take the first steps into hybrid decentralized studies, let alone embrace it on a wide scale.
How Unified Trial Management Future-Proofs Clinical Trials
The nature of managing clinical research has evolved greatly since the initial clinical trial management systems (CTMS) and other early eClinical technologies were introduced. As the traditional trial paradigm has shifted, new technologies have been introduced and existing ones have evolved to keep up with the industry.
Bring Your Medical Device Trials To Market Faster
There’s no denying that the medical device industry has seen a tidal wave of competition in recent years. Forbes forecasted that this $518 billion industry will be a disruptor in the healthcare technology space through 2023, if not longer.